Goodwill And Other Intangible Assets

12 Months Ended

Sep. 30, 2016

Goodwill And Other Intangible Assets [Abstract]

7.Goodwill and Other Intangible Assets

Changes in the carrying amount of goodwill, by reportable segment, for the years ended September 30, 2016 and 2015 were as follows:



(Dollars in Thousands)	Radiation Measurement		Medical Physics		Medical Products		Total
Balance as of September 30, 2015
Goodwill	$	11,002	$	22,611	$	65,527	$	99,140
Accumulated impairment losses		-		-		(64,068)		(64,068)
Balance as of September 30, 2015	$	11,002	$	22,611	$	1,459	$	35,072
Effects of foreign currency - Goodwill		194		-		(784)		(590)
Effects of foreign currency - Accumulated impairment losses		-		-		769		769
Decrease related to dispositions - Goodwill		-		-		(64,743)		(64,743)
Decrease related to dispositions - Accumulated impairment losses		-		-		63,299		63,299
Balance as of September 30, 2016
Goodwill	$	11,196	$	22,611	$	-	$	33,807
Accumulated impairment losses		-		-		-		-
Balance as of September 30, 2016	$	11,196	$	22,611	$	-	$	33,807

Goodwill and certain intangible assets with indefinite lives are reviewed annually for impairment and more frequently if an event occurs or circumstances change that would require the Company to perform an interim review. The Company has three segments: Radiation Measurement; Medical Physics; and Medical Products divested in May 2016.

The Company completed a quantitative assessment for the Radiation Measurement and Medical Physics reporting segments as of September 30, 2016 using the income approach and the market approach, and the estimated fair value of these reporting segments significantly exceeded their carrying values. The discount rates used in this valuation ranged from 9% to 10%.

The Company completed an impairment test for the Medical Products segment as of June 30, 2014 when it became apparent that anticipated revenue and profitability trends in Medical Products were not being achieved to the extent forecasted. Based on the testing performed, the Company recorded a non-cash impairment charge of $62.2 million, of which $41.4 million related to goodwill and $20.8 million related to intangible assets for the fiscal year ended September 30, 2014. The tax benefit associated with the goodwill impairment charge was $15.3 million, and the tax benefit associated with the intangible assets charge was $7.7 million.

During the third quarter of fiscal 2013, the Company performed an impairment analysis with respect to the carrying value of the goodwill in the Medical Products reporting unit. Based on the testing performed, the Company recorded a non-cash goodwill impairment charge of $22.7 million. The tax benefit associated with this charge was $8.5 million.

Intangible assets for the years ended September 30 were as follows:



	2016
(Dollars in Thousands)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Accumulated Intangibles Impairment Charge
Customer lists	$	16,982	$	10,436	$	6,546	$	-
Trademarks and tradenames		133		-		133		-
Licenses and patents		3,397		779		2,618		-
Other intangibles		557		557		-		-
Intangible assets	$	21,069	$	11,772	$	9,297	$	-



	2015
(Dollars in Thousands)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Accumulated Intangibles Impairment Charge
Customer lists	$	43,131	$	33,716		9,415	$	18,657
Trademarks and tradenames		2,181		2,051		130		1,498
Licenses and patents		5,825		2,338		3,487		665
Other intangibles		577		557		20		-
Intangible assets	$	51,714	$	38,662	$	13,052	$	20,820

The decrease in gross carrying amount and accumulated amortization of intangible assets from September 30, 2015 to September 30, 2016 was due primarily to the divestiture of the Medical Products business in May 2016. No customer lists or tradenames were assumed during fiscal 2016 and 2015 relating to business combinations. Amortization of intangible assets was $1,969, $2,243 and $3,978 for the years ended September 30, 2016, 2015 and 2014, respectively. Annual aggregate amortization expense related to intangible assets is estimated to be approximately $1,099 in fiscal 2017, $1,099 in fiscal 2018, $980 in fiscal 2019, $860 in fiscal 2020 and $860 in fiscal 2021.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details